MedTrace Logo

HOLT-ED: Holter-monitoring in End-stage Renal Disease

NCT04876963 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 268

Last updated 2026-05-19

No results posted yet for this study

Summary

The main objective of this prospective cohort study is to assess arrhythmia burden and glycemic variability in a multicenter cohort of patients with end-stage renal disease using a sufficient observation period in order to identify arrhythmia burden and type and characterize associations with patient characteristics and dialysis treatment, glycemic variability and subsequent risk of adverse outcomes.

Conditions

Interventions

DEVICE

Holter-monitor

7-day holtermonitoring of each patient

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Nicholas Carlson, MD PhD · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04876963 on ClinicalTrials.gov